Genenta Science SPA
NASDAQ:GNTA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Genenta Science SPA
NASDAQ:GNTA
|
IT |
|
E
|
Energy Resources Of Australia Ltd
XMUN:EJ7
|
AU |
|
G
|
Groep Brussel Lambert NV
OTC:GBLBF
|
BE |
|
Quebecor Inc
F:QB3
|
CA |
|
Tempest Therapeutics Inc
NASDAQ:TPST
|
US |
|
M
|
MasTec Inc
SWB:MY8
|
US |
|
D
|
Dickson Concepts (International) Ltd
OTC:DCOHF
|
HK |
|
Pick N Pay Stores Ltd
F:PIK
|
ZA |
|
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
|
US |
|
Greenvolt Energias Renovaveis SA
F:000
|
PT |
|
T
|
Tokyo Electron Ltd
F:TKY
|
JP |
|
Las Vegas Sands Corp
NYSE:LVS
|
US |
|
Hiliks Technologies Ltd
BSE:539697
|
IN |
|
Royalty Pharma PLC
F:RPD
|
US |
|
S
|
Swire Properties Ltd
F:SW9
|
HK |
Bankruptcy Probability
Genenta Science SPA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Genenta Science SPA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IT |
|
Genenta Science SPA
NASDAQ:GNTA
|
34.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Genenta Science SPA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Genenta Science SPA has total debt of 7.6m EUR. This includes both short-term (0 EUR) and long-term (7.6m EUR) debt.
You can find a full breakdown on its Balance Sheet.